128 related articles for article (PubMed ID: 1365438)
1. Blockade of N-methyl-D-aspartate receptors potentiates dopaminergic responses in the 6-OHDA model of Parkinson: differential role of D-1 and D-2 receptors.
Morelli M; Fenu S; Di Chiara G
Neurochem Int; 1992 Mar; 20 Suppl():261S-264S. PubMed ID: 1365438
[TBL] [Abstract][Full Text] [Related]
2. Opposite effects of NMDA receptor blockade on dopaminergic D1- and D2-mediated behavior in the 6-hydroxydopamine model of turning: relationship with c-fos expression.
Morelli M; Fenu S; Pinna A; Di Chiara G
J Pharmacol Exp Ther; 1992 Jan; 260(1):402-8. PubMed ID: 1346165
[TBL] [Abstract][Full Text] [Related]
3. Effect of MK 801 on priming of D1-dependent contralateral turning and its relationship to c-fos expression in the rat caudate-putamen.
Morelli M; Fenu S; Carta A; Di Chiara G
Behav Brain Res; 1996 Sep; 79(1-2):93-100. PubMed ID: 8883820
[TBL] [Abstract][Full Text] [Related]
4. Modulation of dopamine D1-mediated turning behavior and striatal c-fos expression by the substantia nigra.
Fenu S; Carta A; Morelli M
Synapse; 1995 Apr; 19(4):233-40. PubMed ID: 7792718
[TBL] [Abstract][Full Text] [Related]
5. D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease.
Paul ML; Graybiel AM; David JC; Robertson HA
J Neurosci; 1992 Oct; 12(10):3729-42. PubMed ID: 1357113
[TBL] [Abstract][Full Text] [Related]
6. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra.
Huang KX; Bergstrom DA; Ruskin DN; Walters JR
Synapse; 1998 Sep; 30(1):18-29. PubMed ID: 9704877
[TBL] [Abstract][Full Text] [Related]
7. Priming of a D1 dopamine receptor behavioural response is dissociated from striatal immediate-early gene activity.
Paul ML; Currie RW; Robertson HA
Neuroscience; 1995 May; 66(2):347-59. PubMed ID: 7477877
[TBL] [Abstract][Full Text] [Related]
8. N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion.
Engber TM; Anderson JJ; Boldry RC; Kuo S; Chase TN
Neuroscience; 1993 Jun; 54(4):1051-61. PubMed ID: 8101981
[TBL] [Abstract][Full Text] [Related]
9. Influence of previous exposure to levodopa on the interaction between dizocilpine and dopamine D1 and D2 agonists in rats with 6-hydroxydopamine-induced lesions.
Boldry RC; Chase TN; Engber TM
J Pharmacol Exp Ther; 1993 Dec; 267(3):1454-9. PubMed ID: 7903390
[TBL] [Abstract][Full Text] [Related]
10. Role of a 35 kDa fos-related antigen (FRA) in the long-term induction of striatal dynorphin expression in the 6-hydroxydopamine lesioned rat.
Bronstein DM; Ye H; Pennypacker KR; Hudson PM; Hong JS
Brain Res Mol Brain Res; 1994 May; 23(3):191-203. PubMed ID: 7914658
[TBL] [Abstract][Full Text] [Related]
11. N-methyl-D-aspartate receptor antagonist and dopamine D1 and D2 agonist interactions in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced hemiparkinsonian monkeys.
Domino EF; Sheng J
J Pharmacol Exp Ther; 1993 Jan; 264(1):221-5. PubMed ID: 8093726
[TBL] [Abstract][Full Text] [Related]
12. MK-801 alters the effects of priming with L-DOPA on dopamine D1 receptor-induced changes in neuropeptide mRNA levels in the rat striatal output neurons.
Van De Witte SV; Groenewegen HJ; Voorn P
Synapse; 2002 Jan; 43(1):1-11. PubMed ID: 11746728
[TBL] [Abstract][Full Text] [Related]
13. A within-subjects microdialysis/behavioural study of the role of striatal acetylcholine in D1-dependent turning.
Acquas E; Fenu S; Loddo P; Di Chiara G
Behav Brain Res; 1999 Sep; 103(2):219-28. PubMed ID: 10513590
[TBL] [Abstract][Full Text] [Related]
14. Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity.
LaHoste GJ; Yu J; Marshall JF
Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7451-5. PubMed ID: 8102797
[TBL] [Abstract][Full Text] [Related]
15. Blockade of muscarinic receptors potentiates D1 dependent turning behavior and c-fos expression in 6-hydroxydopamine-lesioned rats but does not influence D2 mediated responses.
Morelli M; Fenu S; Cozzolino A; Pinna A; Carta A; Di Chiara G
Neuroscience; 1993 Apr; 53(3):673-8. PubMed ID: 8098138
[TBL] [Abstract][Full Text] [Related]
16. Metabolic mapping of the synergism between MK-801 and SKF 38393 in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
Pontieri FE; Morelli M; Orzi F; Terenzi R; Di Chiara G
Synapse; 1992 Dec; 12(4):255-60. PubMed ID: 1465740
[TBL] [Abstract][Full Text] [Related]
17. Dopaminergic transplants suppress L-DOPA-induced Fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease.
Ishida Y; Kuwahara I; Todaka K; Hashiguchi H; Nishimori T; Mitsuyama Y
Brain Res; 1996 Jul; 727(1-2):205-11. PubMed ID: 8842399
[TBL] [Abstract][Full Text] [Related]
18. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.
Pollack AE; Yates TM
Neuroscience; 1999; 94(2):505-14. PubMed ID: 10579212
[TBL] [Abstract][Full Text] [Related]
19. Differential effect of MK 801 and scopolamine on c-fos expression induced by L-dopa in the striatum of 6-hydroxydopamine lesioned rats.
Morelli M; Pinna A; Fenu S; Carta A; Cozzolino A; Di Chiara G
Synapse; 1994 Dec; 18(4):288-93. PubMed ID: 7886620
[TBL] [Abstract][Full Text] [Related]
20. Role of AMPA and NMDA receptors in the nucleus accumbens shell in turning behaviour of rats: interaction with dopamine receptors.
Ikeda H; Akiyama G; Fujii Y; Minowa R; Koshikawa N; Cools AR
Neuropharmacology; 2003 Jan; 44(1):81-7. PubMed ID: 12559124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
